IL15 and Sepsis: Immunoadjuvant therapy using IL-7 and IL-15, administration of interferon γ, and targeting PD-1, particularly to septic patients who exhibit immunosuppressive tendencies, signifies a significant forthcoming breakthrough in the realm of sepsis.